Related Experiment Video
Updated: Jul 17, 2026
09:59
GABA-activated Single-channel and Tonic Currents in Rat Brain Slices
Published on: July 17, 2011
GABA-transaminase in brain and blood platelets: basic and clinical aspects
1Department of Pharmacology, University for Medical Sciences, Tripoli, Libya.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|December 1, 1994
Summary
Gamma-aminobutyric acid (GABA) plays a role in neurological disorders. Studies suggest gamma-aminobutyrate aminotransferase (GABA-T) activity in the brain and platelets relates to conditions like alcoholism and epilepsy.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Gamma-aminobutyric acid (GABA) is a key inhibitory neurotransmitter implicated in neurological and psychiatric disorders.
- Gamma-aminobutyrate aminotransferase (GABA-T) is the primary enzyme responsible for GABA metabolism.
- Elevated brain GABA levels, achieved through GABA-T inhibition, are linked to various pharmacological effects.
Purpose of the Study:
- To explore the role of GABA-T activity in the pathogenesis of neurological and psychiatric disorders.
- To investigate the potential of using GABA-T activity in blood platelets as a biomarker for central nervous system (CNS) disorders.
Main Methods:
- Identification and characterization of GABA-T in human blood platelets.
- Comparison of platelet GABA-T characteristics with brain GABA-T.
- Correlation analysis of GABA-T activity with specific neuropsychiatric conditions.
Main Results:
- GABA-T was identified in blood platelets, exhibiting properties similar to brain GABA-T.
- Evidence suggests a relationship between GABA-T activity and disorders including alcoholism, epilepsy, and Alzheimer's disease.
- Platelet GABA-T activity may serve as a measurable indicator for CNS-related GABAergic dysfunction.
Conclusions:
- GABA-T activity in blood platelets offers a viable avenue for studying GABAergic system dysfunction in neuropsychiatric disorders.
- Understanding GABA-T's role can aid in the diagnosis and treatment of CNS disorders.
- Further research into platelet GABA-T could lead to novel diagnostic and therapeutic strategies for GABA-related disorders.
Related Concept Videos
00:49The Blood-brain Barrier
Overview
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...